Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clonidine hydrochloride
Drug ID BADD_D00503
Description Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors.[A180559] This activity is useful for the treatment of hypertension, severe pain, and ADHD.[L7237,L7240,L7243,L7246] Clonidine was granted FDA approval on 3 September 1974.[L7237]
Indications and Usage May be used as an adjunct in the treatment of hypertension, as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone, for differential diagnosis of pheochromocytoma in hypertensive patients, prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of attention-deficit hyperactivity disorder (ADHD).
Marketing Status Prescription; Discontinued
ATC Code C02AC01; N02CX02; S01EA04
DrugBank ID DB00575
KEGG ID D00604
MeSH ID D003000
PubChem ID 20179
TTD Drug ID D03SKR
NDC Product Code 29300-136; 53002-4940; 53002-4941; 49452-2147; 59212-658; 60760-057; 67296-1196; 70934-851; 50090-3151; 10135-708; 63187-419; 68180-606; 61919-718; 50090-2775; 43353-316; 50090-1909; 71034-001; 59746-668; 63629-1328; 42413-0053; 50090-5089; 60760-178; 71205-570; 66267-061; 0395-8132; 62332-054; 67457-218; 55700-802; 79572-009; 68071-4041; 68382-601; 29300-137; 68788-7685; 50090-5105; 52935-0051; 71335-1624; 61919-605; 50090-5103; 68001-237; 43063-924; 43063-925; 68382-602; 81371-7005; 70518-1283; 70518-3162; 67046-327; 43547-567; 46708-306; 10135-709; 62332-056; 53002-4140; 63629-2318; 60429-431; 46708-308; 63629-7765; 76420-066; 63629-7652; 55700-704; 68071-4545; 61919-268; 43063-817; 71610-449; 66267-062; 71335-0050; 71335-0539; 71335-0121; 61919-266; 29300-468; 42291-148; 70771-1193; 46708-844; 63629-2317; 70518-0481; 68001-239; 68071-4094; 58118-0072; 68788-7145; 45865-797; 70934-752; 70518-3276; 70518-3350; 53747-010; 68071-4661; 63629-2319; 0228-2128; 70518-0350; 68001-238; 0143-9723; 72789-091; 71335-1495; 27241-108; 70518-1811; 66267-464; 51662-1210; 70518-1962; 71205-588; 68071-2631; 50090-1908; 29300-135; 70934-793; 71335-0777; 71205-218; 52817-180; 50090-1910; 62991-1422; 70934-226; 68071-3016; 63629-2316; 0615-2574; 58657-648; 52817-182; 58657-647; 68981-029; 68071-2210; 51927-2379; 60687-462; 0228-2129; 43547-566; 71335-0922; 63629-2314; 68071-4721; 61919-267; 43547-435; 68788-8163; 55154-2577; 50090-4360; 70518-1959; 0228-2127; 63629-1208; 55154-2576; 63629-2753; 58657-649; 52817-181; 67296-0685; 0615-2572; 63629-2315; 53002-4141; 0615-8272; 0143-9724; 68788-8080; 70518-3295; 70771-1194; 0228-4241; 71335-0915; 10135-710; 50090-5577; 51655-339; 60687-124; 68071-4601; 46708-307; 70934-271; 43547-565; 10370-257; 70518-1000; 38779-0561; 60687-113; 70518-0898; 62332-055
Synonyms Clonidine | Klofenil | Clofenil | Chlophazolin | Clonidine Dihydrochloride | Dihydrochloride, Clonidine | Clonidine Hydrochloride | Hydrochloride, Clonidine | Clonidine Monohydrochloride | Monohydrochloride, Clonidine | Clonidine Monohydrobromide | Monohydrobromide, Clonidine | ST-155 | ST 155 | ST155 | Gemiton | Hemiton | Isoglaucon | Klofelin | Clofelin | Clopheline | M-5041T | M 5041T | M5041T | Catapres | Catapresan | Catapressan | Dixarit
Chemical Information
Molecular Formula C9H10Cl3N3
CAS Registry Number 4205-91-8
SMILES C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionDelta-type opioid receptorP41143T58992Not Available
Adverse drug reactionG protein-activated inward rectifier potassium channel 1P48549T38012Not Available
Adverse drug reactionKappa-type opioid receptorP41145T60693Not Available
AgranulocytosisMyeloperoxidaseP05164T23471Not Available
Drug level changedCytochrome P450 3A4P08684T37848Not Available
Drug level increasedCytochrome P450 1A2P05177Not AvailableNot Available
Drug level increasedCytochrome P450 2D6P10635T57392Not Available
Seizures (incl subtypes)G protein-activated inward rectifier potassium channel 1P48549T38012Not Available
Sinus tachycardiaG protein-activated inward rectifier potassium channel 1P48549T38012Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Alcohol intolerance14.02.01.001--
Alopecia23.02.02.001--
Angioedema10.01.05.009; 23.04.01.001--Not Available
Anxiety19.06.02.002--
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Atrioventricular block02.03.01.002--Not Available
Blepharitis23.03.04.012; 06.04.04.001--Not Available
Blood creatine phosphokinase13.04.01.009--Not Available
Blood glucose increased13.02.02.002--Not Available
Bradycardia02.03.02.002--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Chest pain08.01.08.002; 02.02.02.011; 22.02.08.003--Not Available
Conjunctival follicles06.06.02.002--Not Available
Conjunctival oedema06.04.01.001--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Coordination abnormal17.02.02.004--Not Available
Corneal erosion06.06.03.003--Not Available
Corneal infiltrates06.08.01.002--Not Available
Delirium19.13.02.001--
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Discomfort08.01.08.003--Not Available
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages